This article is more than 5 years old. Information may no longer be current.
IOL implantation may be beneficial treatment for congenital cataracts
Click Here to Manage Email Alerts
SAN DIEGO — IOL implantation may be a safe and efficacious treatment option for patients with congenital cataracts, a presenter said here.
Abhay R. Vasavada, MS, FRCS, an OSN Asia-Pacific Edition Editorial Board Member, told colleagues at the American Society of Cataract and Refractive Surgery meeting that 8% to 10% of roughly 270,000 children in India who are blind owe their lack of vision to cataracts.
A prospective, randomized, controlled study assessed 60 pseudophakic eyes and 60 aphakic eyes undergoing bilateral cataract surgery.
"Primary intraocular implantation gave a better and safe outcome in these children with bilateral cataracts," he said.
Visual axis obscuration and synechiae formation did not differ between pseudophakic and aphakic eyes at the 4-year follow-up. However, the incidence of glaucoma was significantly higher in aphakic eyes (P < .03), while visual acuity improvements were significantly higher in pseudophakic eyes (P < .001).
Dr. Vasavada cautioned young surgeons to practice IOL implantation in older children initially and emphasized the need for global awareness in order to facilitate early detection.
- Disclosure: Dr. Vasavada does not have any relevant financial disclosures.